A 57-year-old woman with a history of diabetes and hypertension accidentally overdoses on antiarrhythmic medication. Upon arrival in the ER, she is administered a drug to counteract the effects of the overdose. Which of the following matches an antiarrhythmic with its correct treatment in overdose?
Q492
A 20-year-old woman presents with shortness of breath and chest pain for 1 week. She says the chest pain is severe, sharp in character, and aggravated upon deep breathing. She says she becomes short of breath while walking upstairs in her home or with any type of exertion. She says she frequently feels feverish and fatigued. No significant past medical history and no current medications. Review of systems is significant for a weight loss of 4.5 kg (10.0 lb) over the past month and joint pain in her wrists, hands, and knees. Vital signs are within normal limits. On physical examination, there is a pink rash over her face which is aggravated by sunlight (shown in the image). There are decreased breath sounds on the right. A chest radiograph reveals evidence of a right-sided pleural effusion. Routine urinalysis and urine dipstick are normal. Serum antinuclear antibody (ANA) and anti-double-stranded DNA levels are positive. The patient is started on prednisone therapy and 2 weeks later her CBC is obtained and compared to the one on admission:
On admission
Leukocytes 8,000/mm3
Neutrophils 60%
Lymphocytes 23%
Eosinophils 2%
Basophils 1%
Monocyte 5%
Hemoglobin 10 g/dL
Creatinine 0.8 mg/dL
BUN 15 mg/dL
2 weeks later
Leukocytes 13,000/mm3
Neutrophils 90%
Lymphocytes 8%
Eosinophils 0%
Basophils 0%
Monocyte 1%
Hemoglobin 12g/dL
Creatinine 0.8 mg/dL
BUN 15 mg/dL
Which of the following best describes the most likely mechanism that accounts for the difference between these 2 complete blood counts (CBCs)?
Q493
A 14-year-old boy has undergone kidney transplantation due to stage V chronic kidney disease. A pre-transplantation serologic assessment showed that he is negative for past or present HIV infection, viral hepatitis, EBV, and CMV infection. He has a known allergy for macrolides. The patient has no complaints 1 day after transplantation. His vital signs include: blood pressure 120/70 mm Hg, heart rate 89/min, respiratory rate 17/min, and temperature 37.0°C (98.6°F). On physical examination, the patient appears to be pale, his lungs are clear on auscultation, heart sounds are normal, and his abdomen is non-tender on palpation. His creatinine is 0.65 mg/dL (57.5 µmol/L), GFR is 71.3 mL/min/1.73 m2, and urine output is 0.9 mL/kg/h. Which of the following drugs should be used in the immunosuppressive regimen in this patient?
Q494
A 10-year-old boy presents to the emergency department with a swollen and painful elbow after accidentally bumping his arm into the kitchen table. His mom notes that he seems to bruise and bleed easily, but this is the first time he has had a swollen joint. She also remembers that her uncle had a bleeding disorder, but cannot remember the diagnosis. Physical exam reveals a warm and tender elbow joint, but is otherwise unremarkable. Based on clinical suspicion, a bleeding panel is ordered with the following findings:
Bleeding time: 3 minutes
Prothrombin time (PT): 13 seconds
Partial thromboplastin time (PTT): 54 seconds
Which of the following treatments would most likely be effective in preventing further bleeding episodes for this patient?
Q495
A 45-year-old woman, suspected of having colon cancer, is advised to undergo a contrast-CT scan of the abdomen. She has no comorbidities and no significant past medical history. There is also no history of drug allergy. However, she reports that she is allergic to certain kinds of seafood. After tests confirm normal renal function, she is taken to the CT scan room where radiocontrast dye is injected intravenously and a CT scan of her abdomen is conducted. While being transferred to her ward, she develops generalized itching and urticarial rashes, with facial angioedema. She becomes dyspneic. Her pulse is 110/min, the blood pressure is 80/50 mm Hg, and the respirations are 30/min. Her upper and lower extremities are pink and warm. What is the most appropriate management of this patient?
Q496
A 60-year-old man comes to the emergency room for a persistent painful erection for the last 5 hours. He has a history of sickle cell trait, osteoarthritis, insomnia, social anxiety disorder, gout, type 2 diabetes mellitus, major depressive disorder, and hypertension. He drinks 1 can of beer daily, and smokes marijuana on the weekends. He takes propranolol, citalopram, trazodone, allopurinol, metformin, glyburide, lisinopril, and occasionally ibuprofen. He is alert and oriented but in acute distress. Temperature is 36.5°C(97.7°F), pulse is 105/min, and blood pressure is 145/95 mm Hg. Examination shows a rigid erection with no evidence of trauma, penile discharge, injection, or prosthesis. Which of the following is the most likely cause of his condition?
Q497
A 56-year-old man comes to the physician for a follow-up examination. One month ago, he was diagnosed with a focal seizure and treatment with a drug that blocks voltage-gated sodium channels was begun. Today, he reports that he has not had any abnormal body movements, but he has noticed occasional double vision. His serum sodium is 132 mEq/L, alanine aminotransferase is 49 U/L, and aspartate aminotransferase is 46 U/L. This patient has most likely been taking which of the following drugs?
Q498
A 22-year-old woman comes to the physician to discuss the prescription of an oral contraceptive. She has no history of major medical illness and takes no medications. She does not smoke cigarettes. She is sexually active with her boyfriend and has been using condoms for contraception. Physical examination shows no abnormalities. She is prescribed combined levonorgestrel and ethinylestradiol tablets. Which of the following is the most important mechanism of action of this drug in the prevention of pregnancy?
Q499
A 64-year-old woman presents to the clinic with a history of 3 fractures in the past year with the last one being last month. Her bone-density screening from last year reported a T-score of -3.1 and she was diagnosed with osteoporosis. She was advised to quit smoking and was asked to adapt to a healthy lifestyle to which she complied. She was also given calcium and vitamin D supplements. After a detailed discussion with the patient, the physician decides to start her on weekly alendronate. Which of the following statements best describes this patient’s new therapy?
Q500
A 7-year-old boy presents to an urgent care clinic from his friend’s birthday party after experiencing trouble breathing. His father explains that the patient had eaten peanut butter at the party, and soon after, he developed facial flushing and began scratching his face and neck. This has never happened before but his father says that they have avoided peanuts and peanut butter in the past because they were worried about their son having an allergic reaction. The patient has no significant medical history and takes no medications. His blood pressure is 94/62 mm Hg, heart rate is 125/min, and respiratory rate is 22/min. On physical examination, his lips are edematous and he has severe audible stridor. Of the following, which type of hypersensitivity reaction is this patient experiencing?
Autonomic/CV Drugs US Medical PG Practice Questions and MCQs
Question 491: A 57-year-old woman with a history of diabetes and hypertension accidentally overdoses on antiarrhythmic medication. Upon arrival in the ER, she is administered a drug to counteract the effects of the overdose. Which of the following matches an antiarrhythmic with its correct treatment in overdose?
A. Propafenone and glucose
B. Sotalol and norepinephrine
C. Encainide and epinephrine
D. Quinidine and insulin
E. Esmolol and glucagon (Correct Answer)
Explanation: ***Esmolol and glucagon***
- **Esmolol** is a **beta-blocker**, and **glucagon** can be used in **beta-blocker overdose** to activate adenylate cyclase independently of beta-receptors, increasing intracellular cAMP and improving cardiac contractility and heart rate.
- This pair represents a correct antiarrhythmic drug (esmolol) with its appropriate antidote (glucagon) for overdose management.
*Propafenone and glucose*
- **Propafenone** is a **Class IC antiarrhythmic** that can cause **QRS widening**, but **glucose** is not a specific antidote for its overdose.
- Overdose management for propafenone typically involves sodium bicarbonate for QRS widening and supportive care.
*Sotalol and norepinephrine*
- **Sotalol** is a **beta-blocker** with **Class III antiarrhythmic** properties, and **norepinephrine** is a **vasopressor**.
- While norepinephrine might be used for **hypotension** in sotalol overdose, it is not the primary or specific antidote for reversing the beta-blocking effects; **glucagon** would be more appropriate for the cardiac effects.
*Encainide and epinephrine*
- **Encainide** is a **Class IC antiarrhythmic** drug, and its overdose treatment would generally focus on **sodium bicarbonate** for QRS widening and supportive measures.
- **Epinephrine** is a **vasopressor** and might be used for **hypotension** but is not a specific antidote for encainide overdose.
*Quinidine and insulin*
- **Quinidine** is a **Class IA antiarrhythmic** that primarily blocks **sodium channels** and can cause **QT prolongation** and **QRS widening**.
- **Insulin** is primarily used for **hyperglycemia** or in high-dose insulin therapy for certain drug overdoses (e.g., calcium channel blockers or beta-blockers), but it is not a direct antidote for quinidine overdose.
Question 492: A 20-year-old woman presents with shortness of breath and chest pain for 1 week. She says the chest pain is severe, sharp in character, and aggravated upon deep breathing. She says she becomes short of breath while walking upstairs in her home or with any type of exertion. She says she frequently feels feverish and fatigued. No significant past medical history and no current medications. Review of systems is significant for a weight loss of 4.5 kg (10.0 lb) over the past month and joint pain in her wrists, hands, and knees. Vital signs are within normal limits. On physical examination, there is a pink rash over her face which is aggravated by sunlight (shown in the image). There are decreased breath sounds on the right. A chest radiograph reveals evidence of a right-sided pleural effusion. Routine urinalysis and urine dipstick are normal. Serum antinuclear antibody (ANA) and anti-double-stranded DNA levels are positive. The patient is started on prednisone therapy and 2 weeks later her CBC is obtained and compared to the one on admission:
On admission
Leukocytes 8,000/mm3
Neutrophils 60%
Lymphocytes 23%
Eosinophils 2%
Basophils 1%
Monocyte 5%
Hemoglobin 10 g/dL
Creatinine 0.8 mg/dL
BUN 15 mg/dL
2 weeks later
Leukocytes 13,000/mm3
Neutrophils 90%
Lymphocytes 8%
Eosinophils 0%
Basophils 0%
Monocyte 1%
Hemoglobin 12g/dL
Creatinine 0.8 mg/dL
BUN 15 mg/dL
Which of the following best describes the most likely mechanism that accounts for the difference between these 2 complete blood counts (CBCs)?
A. Redistribution of neutrophils in the lymph nodes
B. Apoptosis of neutrophils
C. Phagocytosis by neutrophils
D. Upregulation of cellular adhesion molecules in the endothelium
E. Downregulation of neutrophil adhesion molecules (Correct Answer)
Explanation: ***Downregulation of neutrophil adhesion molecules***
- The patient's initial presentation suggests **Systemic Lupus Erythematosus (SLE)**, given the lupus-like rash, arthralgia, serositis (pleural effusion), fatigue, weight loss, and positive ANA and anti-dsDNA. She was started on **prednisone**, a corticosteroid.
- **Corticosteroids** like prednisone cause a rapid increase in circulating neutrophils by downregulating **neutrophil adhesion molecules** (e.g., L-selectin). This prevents neutrophils from adhering to the endothelium and migrating into tissues, leading to their accumulation in the blood.
*Redistribution of neutrophils in the lymph nodes*
- Corticosteroids can affect lymphocyte recirculation, but their primary effect on neutrophils is not redistribution into lymph nodes.
- Neutrophils are primarily circulating cells and respond to inflammation by migrating out of the bloodstream into tissues, not typically accumulating in lymph nodes.
*Apoptosis of neutrophils*
- **Apoptosis** (programmed cell death) would lead to a decrease in neutrophil count, which is contrary to the observed increase after prednisone administration.
- Corticosteroids generally **prolong the lifespan of neutrophils** in circulation, contributing to their elevated numbers.
*Phagocytosis by neutrophils*
- Phagocytosis refers to the engulfment of pathogens or debris by neutrophils, a functional activity, not a direct mechanism explaining changes in their circulating numbers due to prednisone.
- While neutrophils are phagocytic cells, this process does not account for the observed increase in their systemic count.
*Upregulation of cellular adhesion molecules in the endothelium*
- **Upregulation of endothelial adhesion molecules** (e.g., ICAM-1, VCAM-1) typically occurs during inflammation, facilitating the transmigration of leukocytes from the blood into tissues.
- Corticosteroids, being anti-inflammatory, generally **reduce the expression of these adhesion molecules**, preventing leukocyte extravasation and contributing to a higher circulating neutrophil count.
Question 493: A 14-year-old boy has undergone kidney transplantation due to stage V chronic kidney disease. A pre-transplantation serologic assessment showed that he is negative for past or present HIV infection, viral hepatitis, EBV, and CMV infection. He has a known allergy for macrolides. The patient has no complaints 1 day after transplantation. His vital signs include: blood pressure 120/70 mm Hg, heart rate 89/min, respiratory rate 17/min, and temperature 37.0°C (98.6°F). On physical examination, the patient appears to be pale, his lungs are clear on auscultation, heart sounds are normal, and his abdomen is non-tender on palpation. His creatinine is 0.65 mg/dL (57.5 µmol/L), GFR is 71.3 mL/min/1.73 m2, and urine output is 0.9 mL/kg/h. Which of the following drugs should be used in the immunosuppressive regimen in this patient?
A. Belatacept
B. Sirolimus
C. Omalizumab
D. Daclizumab
E. Basiliximab (Correct Answer)
Explanation: **Basiliximab**
- **Basiliximab** is a **monoclonal antibody** that targets the **IL-2 receptor (CD25)** on activated T cells, preventing their proliferation and inducing immunosuppression.
- It is commonly used as **induction therapy** in kidney transplant recipients due to its good safety profile, especially in pediatric patients, without the nephrotoxicity associated with calcineurin inhibitors, minimizing acute rejection risks immediately post-transplant.
*Belatacept*
- **Belatacept** works by co-stimulation blockade, binding to **CD80 and CD86** on antigen-presenting cells to prevent T-cell activation.
- It is typically reserved for patients who cannot tolerate calcineurin inhibitors due to **nephrotoxicity** or require a steroid-sparing regimen, which is not indicated as an immediate need in this patient.
*Sirolimus*
- **Sirolimus** is an **mTOR inhibitor** that works by blocking T-cell proliferation and B-cell differentiation.
- It is associated with several side effects, including **delayed wound healing**, **thrombocytopenia**, and **hyperlipidemia**, which are undesirable in the immediate post-transplant period, especially in a growing adolescent.
*Omalizumab*
- **Omalizumab** is an **anti-IgE monoclonal antibody** primarily used for allergic asthma and chronic spontaneous urticaria.
- It has no role in **immunosuppression for organ transplantation** as its mechanism of action is unrelated to preventing graft rejection.
*Daclizumab*
- **Daclizumab** is another **monoclonal antibody** that also targets the **IL-2 receptor (CD25)**, similar to basiliximab.
- However, daclizumab has been **withdrawn from the market** due to serious adverse effects including severe liver injury and autoimmune encephalitis, making it unavailable for clinical use in transplantation.
Question 494: A 10-year-old boy presents to the emergency department with a swollen and painful elbow after accidentally bumping his arm into the kitchen table. His mom notes that he seems to bruise and bleed easily, but this is the first time he has had a swollen joint. She also remembers that her uncle had a bleeding disorder, but cannot remember the diagnosis. Physical exam reveals a warm and tender elbow joint, but is otherwise unremarkable. Based on clinical suspicion, a bleeding panel is ordered with the following findings:
Bleeding time: 3 minutes
Prothrombin time (PT): 13 seconds
Partial thromboplastin time (PTT): 54 seconds
Which of the following treatments would most likely be effective in preventing further bleeding episodes for this patient?
A. von Willebrand factor replacement
B. Platelet administration
C. Vitamin K supplementation
D. Factor VIII replacement (Correct Answer)
E. Intravenous immunoglobulin
Explanation: ***Factor VIII replacement***
- The prolonged **PTT (54 seconds)** with normal PT and bleeding time, combined with a history of **easy bruising and bleeding** and **hemarthrosis** (swollen, painful elbow), is highly indicative of **hemophilia A**, which is caused by a deficiency of Factor VIII.
- **Factor VIII replacement therapy** directly addresses the underlying deficiency in hemophilia A, preventing future bleeding episodes and treating acute bleeds.
*von Willebrand factor replacement*
- **von Willebrand disease** typically presents with a prolonged bleeding time (which is normal in this patient) and can have a prolonged PTT (due to Factor VIII being carried by vWF), but the primary defect is usually in platelet adhesion.
- While vWF replacement is used for von Willebrand disease, this patient's presentation with a normal bleeding time makes it less likely to be the primary cause compared to hemophilia A.
*Platelet administration*
- **Platelet administration** is indicated for conditions involving **thrombocytopenia** (low platelet count) or **platelet dysfunction**, which would typically manifest as a prolonged bleeding time.
- This patient has a **normal bleeding time** and no indication of thrombocytopenia, making platelet administration inappropriate.
*Vitamin K supplementation*
- **Vitamin K** is essential for the synthesis of Factors II, VII, IX, and X, as well as proteins C and S. Deficiency often leads to a **prolonged PT and PTT**.
- This patient has a **normal PT**, ruling out common causes of vitamin K deficiency or liver dysfunction as the primary issue.
*Intravenous immunoglobulin*
- **Intravenous immunoglobulin (IVIG)** is typically used for conditions involving **immune-mediated platelet destruction** (like immune thrombocytopenic purpura, ITP) or certain autoimmune diseases.
- This patient's presentation and lab findings do not suggest an **immune-mediated disorder** or a primary platelet problem that would warrant IVIG.
Question 495: A 45-year-old woman, suspected of having colon cancer, is advised to undergo a contrast-CT scan of the abdomen. She has no comorbidities and no significant past medical history. There is also no history of drug allergy. However, she reports that she is allergic to certain kinds of seafood. After tests confirm normal renal function, she is taken to the CT scan room where radiocontrast dye is injected intravenously and a CT scan of her abdomen is conducted. While being transferred to her ward, she develops generalized itching and urticarial rashes, with facial angioedema. She becomes dyspneic. Her pulse is 110/min, the blood pressure is 80/50 mm Hg, and the respirations are 30/min. Her upper and lower extremities are pink and warm. What is the most appropriate management of this patient?
A. Administer broad-spectrum IV antibiotics
B. Administer vasopressors (norepinephrine and dopamine)
C. Administer IM epinephrine 1:1,000, followed by steroids and antihistamines (Correct Answer)
D. Perform IV resuscitation with colloids
E. Obtain an arterial blood gas analysis
Explanation: ***Administer IM epinephrine 1:1,000, followed by steroids and antihistamines***
- This patient is experiencing **anaphylaxis** due to **radiocontrast dye**, characterized by generalized itching, urticarial rashes, angioedema, dyspnea, hypotension, and tachycardia. **Intramuscular epinephrine (1:1,000 dilution, 0.3-0.5 mg)** is the first-line treatment for anaphylaxis to reverse bronchospasm and hypotension.
- Subsequent administration of **steroids and antihistamines** helps to prevent recurrent or protracted reactions and to reduce inflammatory responses initiated by histamine and other mediators.
*Administer broad-spectrum IV antibiotics*
- This patient's symptoms are consistent with an **allergic reaction (anaphylaxis)**, not an infection, making antibiotics inappropriate.
- There is no clinical evidence of bacterial infection, such as fever, localized inflammation, or signs of sepsis beyond anaphylactic shock.
*Administer vasopressors (norepinephrine and dopamine)*
- While vasopressors can raise blood pressure, they are **second-line agents** for anaphylaxis after epinephrine.
- Epinephrine addresses both the **vasodilation** and **bronchoconstriction** components of anaphylaxis, making it superior as the initial treatment.
*Perform IV resuscitation with colloids*
- **IV fluid resuscitation** is crucial for treating the hypovolemic component of anaphylactic shock, but **crystalloids** are generally preferred over colloids initially.
- **Colloids** do not offer a significant advantage over crystalloids in anaphylaxis, and administering fluids alone would not address the bronchospasm or diffuse mediator release.
*Obtain an arterial blood gas analysis*
- While an ABG can provide information on oxygenation and acid-base status, it is **not the priority** during an acute, life-threatening anaphylactic reaction.
- Immediate management of **airway, breathing, and circulation (ABC)** with epinephrine takes precedence to stabilize the patient.
Question 496: A 60-year-old man comes to the emergency room for a persistent painful erection for the last 5 hours. He has a history of sickle cell trait, osteoarthritis, insomnia, social anxiety disorder, gout, type 2 diabetes mellitus, major depressive disorder, and hypertension. He drinks 1 can of beer daily, and smokes marijuana on the weekends. He takes propranolol, citalopram, trazodone, allopurinol, metformin, glyburide, lisinopril, and occasionally ibuprofen. He is alert and oriented but in acute distress. Temperature is 36.5°C(97.7°F), pulse is 105/min, and blood pressure is 145/95 mm Hg. Examination shows a rigid erection with no evidence of trauma, penile discharge, injection, or prosthesis. Which of the following is the most likely cause of his condition?
A. Citalopram
B. Propranolol
C. Marijuana use
D. Trazodone (Correct Answer)
E. Sickle cell trait
Explanation: ***Trazodone***
- **Trazodone** is well-known to cause **priapism** as a rare but serious side effect, even at therapeutic doses for insomnia or depression.
- The patient's presentation of a **persistent, painful erection** for 5 hours is highly consistent with priapism induced by this medication.
*Citalopram*
- While citalopram (an **SSRI**) can affect sexual function, it typically causes **erectile dysfunction** or ejaculatory problems, not priapism.
- Priapism is not a recognized or common side effect of citalopram.
*Propranolol*
- Propranolol is a **beta-blocker** and is not associated with priapism.
- Its effects on erection are more commonly related to **erectile dysfunction** due to its role in cardiovascular regulation.
*Marijuana use*
- Although marijuana use can impact cardiovascular and neurological systems, there is **no clear evidence** to strongly link it to sustained priapism as a direct cause.
- While theoretically possible through vasodilation, it's a less common cause than certain medications.
*Sickle cell trait*
- While **sickle cell disease** is a common cause of priapism due to venous occlusion, **sickle cell trait** is generally not considered a direct or common cause of priapism.
- Priapism in sickle cell trait is rare and usually associated with other confounding factors or extreme conditions.
Question 497: A 56-year-old man comes to the physician for a follow-up examination. One month ago, he was diagnosed with a focal seizure and treatment with a drug that blocks voltage-gated sodium channels was begun. Today, he reports that he has not had any abnormal body movements, but he has noticed occasional double vision. His serum sodium is 132 mEq/L, alanine aminotransferase is 49 U/L, and aspartate aminotransferase is 46 U/L. This patient has most likely been taking which of the following drugs?
A. Carbamazepine (Correct Answer)
B. Topiramate
C. Lamotrigine
D. Gabapentin
E. Levetiracetam
Explanation: ***Carbamazepine***
- This patient's symptoms of **double vision (diplopia)**, **hyponatremia** (serum sodium 132 mEq/L), and mild elevation in **liver enzymes** (ALT 49 U/L, AST 46 U/L) are classic side effects of carbamazepine.
- Carbamazepine blocks **voltage-gated sodium channels**, which is consistent with the initial treatment description for focal seizures.
- Hyponatremia occurs due to **SIADH (syndrome of inappropriate antidiuretic hormone secretion)**, a well-known adverse effect.
*Topiramate*
- Common side effects include **cognitive slowing**, **paresthesias**, and **kidney stones**, which are not reported by the patient.
- While it can cause weight loss and metabolic acidosis, **diplopia** and **hyponatremia** are not typical adverse effects.
*Lamotrigine*
- Also blocks voltage-gated sodium channels but has a different side effect profile.
- The most significant and potentially life-threatening side effect is a severe skin rash known as **Stevens-Johnson syndrome (SJS)** or toxic epidermal necrolysis (TEN).
- It does not commonly cause **diplopia** or significant **hyponatremia**.
*Gabapentin*
- Primarily acts by binding to the **α2δ subunit of voltage-gated calcium channels** and is NOT a sodium channel blocker.
- Side effects typically include **dizziness**, **somnolence**, and peripheral edema, not the constellation of symptoms presented.
*Levetiracetam*
- Its mechanism of action involves binding to the **synaptic vesicle protein 2A (SV2A)**, a unique target, and it is NOT a voltage-gated sodium channel blocker.
- Common side effects include behavioral changes (**irritability**, **aggression**) and **somnolence**, but not diplopia or hyponatremia.
Question 498: A 22-year-old woman comes to the physician to discuss the prescription of an oral contraceptive. She has no history of major medical illness and takes no medications. She does not smoke cigarettes. She is sexually active with her boyfriend and has been using condoms for contraception. Physical examination shows no abnormalities. She is prescribed combined levonorgestrel and ethinylestradiol tablets. Which of the following is the most important mechanism of action of this drug in the prevention of pregnancy?
A. Inhibition of rise in luteinizing hormone (Correct Answer)
B. Suppression of ovarian folliculogenesis
C. Thickening of cervical mucus
D. Prevention of endometrial proliferation
E. Increase of sex-hormone binding globulin
Explanation: ***Inhibition of rise in luteinizing hormone***
- Combined oral contraceptives (COCs) primarily prevent pregnancy by **suppressing the hypothalamic-pituitary-ovarian axis**, which inhibits the mid-cycle **Luteinizing Hormone (LH) surge** necessary for ovulation.
- Without the LH surge, the mature follicle does not rupture, and the **ovum is not released**.
*Suppression of ovarian folliculogenesis*
- While COCs do **suppress follicular development**, this is a consequence of the feedback inhibition on FSH secretion, and not the primary contraceptive mechanism.
- The direct **prevention of ovulation** via LH surge inhibition is the most crucial step.
*Thickening of cervical mucus*
- Progestin components of COCs cause the **cervical mucus to become thick and impermeable** to sperm, acting as a secondary contraceptive mechanism.
- However, this is not the most important or primary mechanism, as ovulation can still be theoretically prevented even without this effect.
*Prevention of endometrial proliferation*
- The progestin in COCs causes the endometrium to become **thin and atrophic**, making it less receptive to implantation.
- This is an **ancillary contraceptive effect** but not the primary way pregnancy is prevented, as preventing ovulation is more fundamental.
*Increase of sex-hormone binding globulin*
- Estrogen in COCs can **increase levels of sex hormone-binding globulin (SHBG)**, affecting the bioavailability of endogenous androgens.
- This effect is largely responsible for reducing symptoms of androgen excess (e.g., acne) but plays **no direct role in contraception**.
Question 499: A 64-year-old woman presents to the clinic with a history of 3 fractures in the past year with the last one being last month. Her bone-density screening from last year reported a T-score of -3.1 and she was diagnosed with osteoporosis. She was advised to quit smoking and was asked to adapt to a healthy lifestyle to which she complied. She was also given calcium and vitamin D supplements. After a detailed discussion with the patient, the physician decides to start her on weekly alendronate. Which of the following statements best describes this patient’s new therapy?
A. It should be stopped after 10 years due to the risk of esophageal cancer
B. It is typically used as a second-line therapy for her condition after raloxifene
C. It can cause hot flashes, flu-like symptoms, and peripheral edema
D. It must be taken with the first meal of the day due to the significant risk of GI upset
E. The patient must stay upright for at least 30 minutes after taking this medication (Correct Answer)
Explanation: ***The patient must stay upright for at least 30 minutes after taking this medication***
- This instruction is crucial for **alendronate** (a bisphosphonate) to prevent **esophageal irritation** and potential esophagitis or ulcers.
- Alendronate must be taken with a full glass of plain water on an **empty stomach** at least 30-60 minutes before the first food, beverage, or other medication of the day, and the patient must remain upright.
*It should be stopped after 10 years due to the risk of esophageal cancer*
- The main concern with long-term bisphosphonate use (usually >5 years for oral agents) is the risk of **atypical femoral fractures** and **osteonecrosis of the jaw**, not esophageal cancer.
- While esophageal irritation is a known side effect, the risk of esophageal cancer is **not the primary reason** for treatment discontinuation after 10 years.
*It is typically used as a second-line therapy for her condition after raloxifene*
- **Alendronate** (an oral bisphosphonate) is considered a **first-line therapy** for postmenopausal osteoporosis, especially in patients with a history of fractures and low T-scores.
- **Raloxifene** is a selective estrogen receptor modulator (SERM) typically used when bisphosphonates are contraindicated or not tolerated, or there is a need to also treat breast cancer risk, and it is **less potent** in reducing non-vertebral fractures.
*It can cause hot flashes, flu-like symptoms, and peripheral edema*
- These side effects (hot flashes, flu-like symptoms, peripheral edema) are **not typically associated** with alendronate.
- **Hot flashes** are more common with estrogen-modulating drugs like raloxifene, while **flu-like symptoms** can occur with IV bisphosphonates (like zoledronic acid) or certain anabolic agents.
*It must be taken with the first meal of the day due to the significant risk of GI upset*
- This statement is incorrect; alendronate must be taken on an **empty stomach** (at least 30-60 minutes before the first food or drink) to ensure adequate absorption.
- Taking it with food or other beverages significantly **reduces its absorption**, making it less effective, and the risk of GI upset (specifically esophageal irritation) is why remaining upright and taking with water are stressed.
Question 500: A 7-year-old boy presents to an urgent care clinic from his friend’s birthday party after experiencing trouble breathing. His father explains that the patient had eaten peanut butter at the party, and soon after, he developed facial flushing and began scratching his face and neck. This has never happened before but his father says that they have avoided peanuts and peanut butter in the past because they were worried about their son having an allergic reaction. The patient has no significant medical history and takes no medications. His blood pressure is 94/62 mm Hg, heart rate is 125/min, and respiratory rate is 22/min. On physical examination, his lips are edematous and he has severe audible stridor. Of the following, which type of hypersensitivity reaction is this patient experiencing?
A. Type II hypersensitivity reaction
B. Type III hypersensitivity reaction
C. Type I hypersensitivity reaction (Correct Answer)
D. Type IV hypersensitivity reaction
E. Combined type I and type III hypersensitivity reactions
Explanation: ***Type I hypersensitivity reaction***
- This patient is experiencing **anaphylaxis** due to **peanut exposure**, a classic example of a **Type I hypersensitivity reaction**. This involves **IgE-mediated mast cell and basophil degranulation**, releasing histamines and other inflammatory mediators.
- The symptoms like **facial flushing, itching, angioedema (edematous lips), stridor (upper airway obstruction), tachycardia**, and potentially **hypotension** (blood pressure 94/62 mmHg in a child suggests relative hypotension) are all consistent with a severe systemic allergic reaction.
*Type II hypersensitivity reaction*
- Type II hypersensitivity involves **antibody-mediated cytotoxicity**, where **IgG or IgM antibodies** bind to antigens on cell surfaces, leading to cell destruction.
- This type of reaction typically manifests as **hemolytic anemia, thrombocytopenia**, or **Goodpasture syndrome**, which are distinct from the patient's acute allergic presentation.
*Type III hypersensitivity reaction*
- Type III hypersensitivity is characterized by the formation of **immune complexes** (antigen-antibody complexes) that deposit in tissues, leading to inflammation and tissue damage.
- Conditions like **serum sickness, lupus nephritis**, or **Arthus reaction** are examples of Type III reactions and do not fit the acute, IgE-mediated symptoms seen in this patient.
*Type IV hypersensitivity reaction*
- Type IV hypersensitivity is a **delayed-type hypersensitivity** reaction mediated by **T-cells**, not antibodies. It takes 24-72 hours to develop.
- Examples include **contact dermatitis (e.g., poison ivy)**, **tuberculin skin test reactions**, or **graft rejection**, which are much slower and have different mechanisms than the immediate anaphylactic response described.
*Combined type I and type III hypersensitivity reactions*
- While some complex immune conditions might involve multiple types of hypersensitivity over time, the patient's acute, rapid-onset symptoms after peanut ingestion are overwhelmingly characteristic of a **primary Type I hypersensitivity reaction**.
- There is no clinical evidence in this presentation to suggest the involvement of **immune complex deposition** (Type III) in addition to the immediate IgE-mediated response.